Skip to content
Pharma Observatory a Scientist.com platform

Organization (Other)

Ukrainian Society of Regional Anesthesia and Pain Therapy

ClinicalTrials.gov lists Ukrainian Society of Regional Anesthesia and Pain Therapy as lead sponsor of 12 trials. It has 25 active development programs and 1 approved asset.

Other
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Disease areas Disease areas 23 Trials by start year as sponsor or collaborator Trials by start year as sponsor or collaborator 1 Active development programs Active development programs 25 Approved assets Approved assets 1 Sponsor delivery record Sponsor delivery record 1 Journals published in Journals published in 7 Latest dated events Latest dated events 12 Disease areas Disease areas 23 Trials by start year as sponsor or collaborator Trials by start year as sponsor or collaborator 1 Active development programs Active development programs 25 Approved assets Approved assets 1 Sponsor delivery record Sponsor delivery record 1 Journals published in Journals published in 7 Latest dated events Latest dated events 12

Rows recorded per section (log scale)

17 sections measured, none recorded

This page covers Ukrainian Society of Regional Anesthesia and Pain Therapy: 12 lead-sponsored trials and 0 legal-entity registrations.

Get the Ukrainian Society of Regional Anesthesia and Pain Therapy report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Disease areas (23)

Shown in this order: most trials first.

Disease areas
Disease area Trials
Pain 8
Neuralgia 4
Neuroma 4
Phantom Limb 3
Postoperative Pain 3

Showing 5 of 23 disease areas.

Start your 14-day trial Email me all 23 disease areas as a PDF

Trials by start year as sponsor or collaborator (1)

Trials by start year as sponsor or collaborator
Year Trials started
2026 (partial year) 12

No forecast is made for this organization: it averages 1.6 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.

Active development programs (25)

Shown in this order: max phase, then active trials.

Active development programs
Drug Disease area Max phase Trials
Radiofrequency ablation alone Neuralgia Not reported 1
Radiofrequency ablation alone Neuroma Not reported 1
Radiofrequency ablation alone Agnosia Not reported 1
Radiofrequency ablation alone Hypesthesia Not reported 1
Radiofrequency ablation alone Pain Not reported 1

Showing 5 of 25 active programs.

Start your 14-day trial Email me all 25 active programs as a PDF

Approved assets (1)

Approved assets
Drug Trials
BOTULINUM TOXIN TYPE-A 1

Sponsor delivery record (1)

Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.

Sponsor delivery record
Enrollment Timeline
3 of 3 hit target (n=3) 1 of 3 on time (n=3)

Journals published in (7)

Shown in this order: most published in first.

Journals published in
Journal Publications
Military medicine 2
Clinical drug investigation 1
Medical science monitor : international medical journal of experimental and clinical research 1
Regional anesthesia and pain medicine 1
Shock (Augusta, Ga.) 1

Showing 5 of 7 journals.

Start your 14-day trial Email me all 7 journals as a PDF

Latest dated events (12)

Shown in this order: newest first.

Latest dated events
Date Event Source
2026-10-23 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-10-15 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-10-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-10-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-09-23 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))

Showing 5 of 12 events.

Start your 14-day trial Email me all 12 events as a PDF

Not on this page

Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, organization relationships, clia clinical laboratory certificates, biomarker capability evidence, and biomarkers this organization publishes on.